Skip to content
Search

Latest Stories

Research shows middle-age Covid-19 mortality risk

Middle-aged people, and not just the elderly, have a dramatically higher risk of dying or developing serious illness from Covid-19, new research from Britain showed Tuesday (31).

The findings came in a new comprehensive analysis of virus cases in mainland China.


Researchers from Britain analysed more than 3,600 confirmed Covid-19 cases as well as data from hundreds of passengers repatriated from the outbreak city of Wuhan.

They found that age was a key determining factor in serious infections, with nearly one in five over-80s requiring hospitalisation, compared to around 1 percent among people under 30.

Taking into account estimates of the number of cases that may not have been clinically confirmed - that is, mild or asymptomatic infections - the data showed the hospitalisation rate of patients in their fifties was 8.2 per cent.

The study, published in The Lancet Infectious Diseases journal, estimated that the mortality rate from confirmed Covid-19 cases in mainland China was 1.38 per cent.

If unconfirmed cases were taken into account, the death rate dropped to 0.66 per cent.

The authors of the research said that while this was significantly lower than previous estimates, Covid-19 is still several times deadlier than previous pandemic viruses, such as H1N1.

"Our estimates can be applied to any country to inform decisions around the best containment policies for Covid-19," said Azra Ghani, a study co-author from Imperial College London.

"There might be outlying cases that get a lot of media attention, but our analysis very clearly shows that at aged 50 and over, hospitalisation is much more likely than in those under 50, and a greater proportion of cases are likely to be fatal."

Billions of people have been confined to their homes around the world as governments desperately try to stop the spread of the novel coronavirus.

As of 1900 GMT Monday (30) the virus had killed 36,374 people out of 757,940 cases globally.

That would mean 4.8 per cent of all confirmed Covid-19 infections have proven deadly.

But experts stress that without widespread testing it is impossible to know how many people may have become infected and recovered.

This means the true mortality rate is likely much lower, in line with The Lancet study and previous research from China.

The Lancet study showed that 18.4 per cent of patients in their 80s were hospitalised in China.

This compared to 4.3 percent for 40 to 49-year-olds and roughly 1 percent for people in their 20s.

According to their modelling, the authors estimate that 50-80 percent of the global population could contract Covid-19 but that came with several caveats, as modelling can't account for behavioural changes such as hand washing and social distancing.

Devi Sridhar, professor and chair of Global Public Health, at the University of Edinburgh's Medical School, said that the assumption that most people would become infected was leading governments, including in Britain, to abandon measures that could help slow the pandemic.

She tweeted on Tuesday that the models "resulted in the UK giving up on containment too early & assuming everyone will get it.

"Planning & preparing for unprecedented testing & using big data/apps for tracing were taken off the table. In my view, we went down the wrong path," she said.

More For You

Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less